.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Deloitte
Chubb
Argus Health
Cerilliant
Medtronic
UBS
Healthtrust
QuintilesIMS
Cipla

Generated: September 20, 2017

DrugPatentWatch Database Preview

MOXATAG Drug Profile

« Back to Dashboard

Which patents cover Moxatag, and when can generic versions of Moxatag launch?

Moxatag is a drug marketed by Vernalis R And D Ltd and is included in one NDA. There are six patents protecting this drug.

This drug has thirty-seven patent family members in six countries.

The generic ingredient in MOXATAG is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

Summary for Tradename: MOXATAG

Patents:6
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list36
Patent Applications: see list7,439
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MOXATAG at DailyMed

Pharmacology for Tradename: MOXATAG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: MOXATAG

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,108,859Antineoplastic product, use and formulation thereof► Subscribe
7,157,095Multiple-delayed release antifungal product, use and formulation thereof► Subscribe
6,541,014 Antiviral product, use and formulation thereof► Subscribe
6,667,057 Levofloxacin antibiotic product, use and formulation thereof► Subscribe
6,667,042 Fluroquinilone antibiotic product, use and formulation thereof► Subscribe
7,282,221Antiviral product, use and formulation thereof► Subscribe
6,663,891 Erythromyacin antibiotic product, use and formulation thereof► Subscribe
8,889,187Once a day amoxicillin product comprising immediate and delayed release dosage forms► Subscribe
7,105,174Multiple-delayed release anti-neoplastic product, use and formulation thereof► Subscribe
7,025,989Multiple-delayed released antibiotic product, use and formulation thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MOXATAG

Country Document Number Estimated Expiration
European Patent Office1465591► Subscribe
Japan2010511607► Subscribe
Canada2494015► Subscribe
European Patent Office1257255► Subscribe
Canada2635378► Subscribe
Japan2005538121► Subscribe
European Patent Office1542656► Subscribe
Japan2006500344► Subscribe
Australia2003261359► Subscribe
Australia2003257176► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
QuintilesIMS
Chinese Patent Office
Boehringer Ingelheim
McKesson
Fuji
AstraZeneca
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot